638 related articles for article (PubMed ID: 10438745)
21. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis.
Dhar N; Rao V; Tyagi AK
FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297
[TBL] [Abstract][Full Text] [Related]
22. A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strains.
Chen JM; Uplekar S; Gordon SV; Cole ST
PLoS One; 2012; 7(8):e43467. PubMed ID: 22912881
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
Altaf M; Miller CH; Bellows DS; O'Toole R
Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
[TBL] [Abstract][Full Text] [Related]
24. The Influence of Mycobacterium tuberculosis sigma factors on the promotion efficiency of ptpAt promoter in Mycobacterium smegmatis.
Lei J; Zhang H; Wu C; Wang X; Yang Y; Zhang X; Huang Y; Wang H
Curr Microbiol; 2005 Sep; 51(3):141-7. PubMed ID: 16091848
[TBL] [Abstract][Full Text] [Related]
25. Transcription analysis of the dnaA gene and oriC region of the chromosome of Mycobacterium smegmatis and Mycobacterium bovis BCG, and its regulation by the DnaA protein.
Salazar L; Guerrero E; Casart Y; Turcios L; Bartoli F
Microbiology (Reading); 2003 Mar; 149(Pt 3):773-784. PubMed ID: 12634345
[TBL] [Abstract][Full Text] [Related]
26. The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin.
Reyrat JM; Berthet FX; Gicquel B
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8768-72. PubMed ID: 7568014
[TBL] [Abstract][Full Text] [Related]
27. Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis.
DiChiara JM; Contreras-Martinez LM; Livny J; Smith D; McDonough KA; Belfort M
Nucleic Acids Res; 2010 Jul; 38(12):4067-78. PubMed ID: 20181675
[TBL] [Abstract][Full Text] [Related]
28. The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis.
Flint JL; Kowalski JC; Karnati PK; Derbyshire KM
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12598-603. PubMed ID: 15314236
[TBL] [Abstract][Full Text] [Related]
29. Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains.
Seki M; Honda I; Fujita I; Yano I; Yamamoto S; Koyama A
Vaccine; 2009 Mar; 27(11):1710-6. PubMed ID: 19200449
[TBL] [Abstract][Full Text] [Related]
30. Insertional mutagenesis and illegitimate recombination in mycobacteria.
Kalpana GV; Bloom BR; Jacobs WR
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5433-7. PubMed ID: 2052623
[TBL] [Abstract][Full Text] [Related]
31. The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.
Prados-Rosales R; Carreño LJ; Weinrick B; Batista-Gonzalez A; Glatman-Freedman A; Xu J; Chan J; Jacobs WR; Porcelli SA; Casadevall A
J Infect Dis; 2016 Aug; 214(3):426-37. PubMed ID: 27234419
[TBL] [Abstract][Full Text] [Related]
32. A novel differential expression system for gene modulation in Mycobacteria.
Fan XY; Ma H; Guo J; Li ZM; Cheng ZH; Guo SQ; Zhao GP
Plasmid; 2009 Jan; 61(1):39-46. PubMed ID: 18835406
[TBL] [Abstract][Full Text] [Related]
33. Efficient construction of unmarked recombinant mycobacteria using an improved system.
Yang F; Tan Y; Liu J; Liu T; Wang B; Cao Y; Qu Y; Lithgow T; Tan S; Zhang T
J Microbiol Methods; 2014 Aug; 103():29-36. PubMed ID: 24873745
[TBL] [Abstract][Full Text] [Related]
34. Comparison of mammalian cell entry operons of mycobacteria: in silico analysis and expression profiling.
Kumar A; Chandolia A; Chaudhry U; Brahmachari V; Bose M
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):185-95. PubMed ID: 15681149
[TBL] [Abstract][Full Text] [Related]
35. Construction of Novel Live Genetically Modified BCG Vaccine Candidates Using Recombineering Tools.
Flores-Valdez MA; Aceves-Sánchez MJ
Methods Mol Biol; 2022; 2410():367-385. PubMed ID: 34914058
[TBL] [Abstract][Full Text] [Related]
36. Positive selection of allelic exchange mutants in Mycobacterium bovis BCG.
Pelicic V; Reyrat JM; Gicquel B
FEMS Microbiol Lett; 1996 Nov; 144(2-3):161-6. PubMed ID: 8900059
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection.
Ciaramella A; Cavone A; Santucci MB; Garg SK; Sanarico N; Bocchino M; Galati D; Martino A; Auricchio G; D'Orazio M; Stewart GR; Neyrolles O; Young DB; Colizzi V; Fraziano M
J Infect Dis; 2004 Sep; 190(6):1167-76. PubMed ID: 15319868
[TBL] [Abstract][Full Text] [Related]
38. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterial recombineering.
van Kessel JC; Hatfull GF
Methods Mol Biol; 2008; 435():203-15. PubMed ID: 18370078
[TBL] [Abstract][Full Text] [Related]
40. Identification of the mycobacterial glucosyl-3-phosphoglycerate synthase.
Empadinhas N; Albuquerque L; Mendes V; Macedo-Ribeiro S; da Costa MS
FEMS Microbiol Lett; 2008 Mar; 280(2):195-202. PubMed ID: 18221489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
